Prognostic Risk Stratification and End-of-Life Care Outcomes in Patients With Metastatic Melanoma Treated With Immune Checkpoint Inhibitors

INTRODUCTION: The emergence of immune checkpoint inhibitors (ICIs) has improved survival outcomes in patients with metastatic melanoma, while potentially increasing the use of systemic therapy near the end of life (EOL). Yet, less is known on how to facilitate treatment decision making and identify...

Descripción completa

Detalles Bibliográficos
Autores principales: Grad, Robert N, Jung, Seungyeon, Ye, Fei, Sun, Lili, Johnson, Douglas B, Agarwal, Rajiv
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Melanoma and Cutaneous Malignancies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10546833/
https://www.ncbi.nlm.nih.gov/pubmed/37543031
http://dx.doi.org/10.1093/oncolo/oyad219

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10546833/
https://www.ncbi.nlm.nih.gov/pubmed/37543031
http://dx.doi.org/10.1093/oncolo/oyad219

Ejemplares similares